CRTonline Podcast
Kanal tafsilotlari
CRTonline Podcast
CRTonline Podcast is a collection of interviews with well renowned physicians on medical journals and on-going issues around the world of medicine.
So'nggi epizodlar
373 epizod
INNOVATION COMPETITION: Retrievable Scaffold Therapy: The Spur Elute Coronary Retrievable Scaffold System
INNOVATION COMPETITION: Retrievable Scaffold Therapy: The Spur Elute Coronary Retrievable Scaffold System
LBCT: Effect Of Low-dose Dobutamine Infusion On N-terminal Pro B-type Natriuretic Peptide In Risk Patients With Acute Myocardial Infarction (DOBERMANN-D) - A Randomized Clinical Trial
LBCT: Effect Of Low-dose Dobutamine Infusion On N-terminal Pro B-type Natriuretic Peptide In Risk Patients With Acute Myocardial Infarction (DOBERMANN...
LBCT: Novel Balloon-expandable Transcatheter Heart Valve For Aortic Stenosis: Initial Insights From The Early Feasibility Study
LBCT: Novel Balloon-expandable Transcatheter Heart Valve For Aortic Stenosis: Initial Insights From The Early Feasibility Study
Wellness of Female Interventional Cardiologists in the Cath Lab
Wellness of Female Interventional Cardiologists in the Cath Lab
Wellness of Interventional Cardiologists in the Cath Lab
Wellness of Interventional Cardiologists in the Cath Lab
Comparison of a Hands-Free, Fully Automated Segmentation Angiography-Derived Fractional Flow Reserve, X1-FFR, With Invasive Wire-based Hyperemic FFR
Comparison of a Hands-Free, Fully Automated Segmentation Angiography-Derived Fractional Flow Reserve, X1-FFR, With Invasive Wire-based Hyperemic FFR
King and I | S6 E8 | Long-Term Follow-Up after TAVR and What Signal Should be Urgently Reported to the Public
King and I | S6 E8 | Long-Term Follow-Up after TAVR and What Signal Should be Urgently Reported to the Public
LBCT: Real-World Reintervention Rate Among TAVR Low-Risk Medicare Patients
LBCT: Real-World Reintervention Rate Among TAVR Low-Risk Medicare Patients
AI-Enabled ECG Interpretation in STEMI: Findings from a Multicenter U.S. Registry
AI-Enabled ECG Interpretation in STEMI: Findings from a Multicenter U.S. Registry
Immediate Instantaneous Wave-Free Ratio Guided Versus Deferred Cardiac Magnetic Resonance Imaging Guided Revascularization of Non-Culprit Lesions
Immediate Instantaneous Wave-Free Ratio Guided Versus Deferred Cardiac Magnetic Resonance Imaging Guided Revascularization of Non-Culprit Lesions
STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus
STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus
PROCTOR: A Multicenter, Open-label, Randomized Trial
PROCTOR: A Multicenter, Open-label, Randomized Trial
3-Year Clinical Outcomes of the REC-CAGEFREE I Trial
3-Year Clinical Outcomes of the REC-CAGEFREE I Trial
Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study
Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study
Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial
Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial
Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
Results from STORM-PE - Randomized Controlled Trial
Results from STORM-PE - Randomized Controlled Trial
The VICTORY Trial - A Randomized, Multicenter, Non-Inferiority Comparison
The VICTORY Trial - A Randomized, Multicenter, Non-Inferiority Comparison
Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis
Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis
One-Year Results of the SELUTION DeNovo Tria
One-Year Results of the SELUTION DeNovo Tria
King and I | S6 E5 | PCI: Back to the Balloon
King and I | S6 E5 | PCI: Back to the Balloon
King and I | S6 E4 | Who Needs MCS for High-Risk PCI
King and I | S6 E4 | Who Needs MCS for High-Risk PCI
Impact of Cerebral Embolic Protection on Cognition: Experience from BHF PROTECT-TAVI
Impact of Cerebral Embolic Protection on Cognition: Experience from BHF PROTECT-TAVI
OPTION-STEMI: Timing of Complete Revascularization During Index Hospitalization in Patients with STEMI and Multivessel Disease
OPTION-STEMI: Timing of Complete Revascularization During Index Hospitalization in Patients with STEMI and Multivessel Disease
Age Analysis of the MCS in CS Meta Analysis
Age Analysis of the MCS in CS Meta Analysis
IPD Meta-Analysis of Contemporary Trials Comparing TAVI versus SAVR
IPD Meta-Analysis of Contemporary Trials Comparing TAVI versus SAVR
Long-term Outcomes of the DanGer Shock Trial
Long-term Outcomes of the DanGer Shock Trial
TACSI: Dual or Single Antiplatelet Therapy After CABG in ACS Patients
TACSI: Dual or Single Antiplatelet Therapy After CABG in ACS Patients
DAPT-SHOCK-AMI Trial: Cangrelor in Cardiogenic Shock
DAPT-SHOCK-AMI Trial: Cangrelor in Cardiogenic Shock
TARGET-FIRST: Early Aspirin Discontinuation After PCI in Acute MI Patients
TARGET-FIRST: Early Aspirin Discontinuation After PCI in Acute MI Patients
TAILORED-CHIP: Tailored Antiplatelet Therapy for Complex High-Risk PCI
TAILORED-CHIP: Tailored Antiplatelet Therapy for Complex High-Risk PCI